Drug recall · February 17, 2016
Pramipexole Dihydrochloride Tablets 0.125 mg recall
Why: Presence of Foreign Tablets/Capsules: Presence of a comingled Carbimazole 5 mg tablet.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Pramipexole Dihydrochloride Tablets 0.125 mg, 90 Ct Bottles, Rx Only. Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, INDIA. NDC: 33342-031-10.
- Lots / codes
Lot #: BPA512A; Expiry: 06/2017.
- Quantity
- N/A
- Company
- Macleods Pharma Usa Inc, Plainsboro, NJ
- Distribution
- US Nationwide.
- Initiated
- December 24, 2015 · Voluntary: Firm initiated
- Classified
- February 5, 2016
- Reported
- February 17, 2016
- Ended
- August 31, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pramipexole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.